How to bring an orphan drug to market – why is there legislation for rare diseases?

orphan drugs legislation Orphan drugs trainer Elizabeth Hernberg-Ståhl looks at why there is legislation for drugs for rare diseases in this video extract.

She discusses the Orphan Drug Act of 1983 and looks at the driving forces behind its introduction, as well as how it has helped to stimulate the orphan drugs industry since.

To find out more about the orphan drugs industry and the legislation involved, why not try a free sample of the online 12 Hour MBA in Orphan Drugs training course?

Feel free to contact me at if you have any queries!

Leave a Reply

Your email address will not be published. Required fields are marked *